These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2820640

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparative assessment of phospholipid-binding antibodies indicates limited overlapping.
    de Maistre E, Gobert B, Béné MC, Briquel ME, Lecompte T, Faure GC.
    J Clin Lab Anal; 1996; 10(1):6-12. PubMed ID: 8926568
    [Abstract] [Full Text] [Related]

  • 23. ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.
    Wassef NM, Swartz GM, Alving BM, Alving CR.
    Biochem Biophys Res Commun; 1993 Jan 29; 190(2):582-8. PubMed ID: 8381281
    [Abstract] [Full Text] [Related]

  • 24. Lipid A and liposomes containing lipid A as antigens and adjuvants.
    Alving CR, Rao M.
    Vaccine; 2008 Jun 06; 26(24):3036-45. PubMed ID: 18226433
    [Abstract] [Full Text] [Related]

  • 25. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease.
    Drouvalakis KA, Buchanan RR.
    J Rheumatol; 1998 Feb 06; 25(2):290-5. PubMed ID: 9489821
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
    Pattison NS, McKay EJ, Liggins GC, Lubbe WF.
    N Z Med J; 1987 Feb 11; 100(817):61-4. PubMed ID: 3103033
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A.
    Matyas GR, Alving CR.
    Vaccine; 2011 Jul 18; 29(32):5137-44. PubMed ID: 21624414
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
    Subang R, Levine JS, Janoff AS, Davidson SM, Taraschi TF, Koike T, Minchey SR, Whiteside M, Tannenbaum M, Rauch J.
    J Autoimmun; 2000 Aug 18; 15(1):21-32. PubMed ID: 10936025
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effective induction of anti-phospholipid and anticoagulant antibodies in normal mouse.
    Igarashi K, Umeda M, Tokita S, Nam KS, Inoue K.
    Thromb Res; 1991 Jan 15; 61(2):135-48. PubMed ID: 1902329
    [Abstract] [Full Text] [Related]

  • 37. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.
    Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B, Allegri F, Balestrieri G, Valesini G, Shoenfeld Y.
    J Autoimmun; 1994 Aug 15; 7(4):441-55. PubMed ID: 7980847
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 15; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.